Genetic risk loci for Parkinson's disease: Moving from state to trait?

Movement Disorders

Volumn 30, Issue 6, 2015, Pages 747-749

  Kasten, Meike ^a   Klein, Christine ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN G; CYCLIN G ASSOCIATED KINASE; DIACYLGLYCEROL KINASE; DIACYLGLYCEROL KINASE THETA; GLUCOSYLCERAMIDASE; MEMBRANE PROTEIN; PROTEIN SLC26A1; TRANSMEMBRANE PROTEIN 175; UNCLASSIFIED DRUG;

AGE; ALLELE; ARTICLE; CLINICAL EVALUATION; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PRACTICE; DISEASE COURSE; EFFECT SIZE; FOLLOW UP; GBA GENE; GENE; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC SELECTION; HUMAN; META ANALYSIS (TOPIC); MOTOR PERFORMANCE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STANDARDIZATION; AGING; ECONOMICS; GENETIC PREDISPOSITION; GENETICS; PATHOPHYSIOLOGY; PROCEDURES; TRENDS;

AGING; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84929655014     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26246     Document Type: Article

References (8)

1. Lill CM, Roehr JT, McQueen MB, et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet 2012;8:e1002548.
2. Nalls MA, Pankratz N, Lill CM, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat Genet 2014;46:989-993.
3. Nalls MA, Escott-Price V, Williams NM, Lubbe S, Keller MF, Morris HR, Singelton AB. Genetic risk and age in Parkinson's disease: continuum not stratum. Mov Disord 2015;30:850-854.
4. Lill CM, Hansen J, Olsen JH, Binder H, Ritz B, Bertram L. Impact of Parkinson's disease risk loci on age at onset. Mov Disord 2015;30:847-850.
5. Alcalay RN, Dinur T, Quinn T, et al. Comparison of Parkinson risk in Ashkenazi Jewish patiets with Gaucher disease and GBA heterozygotes. JAMA Neurol 2014;71:752-757.
6. Klein C, Ziegler A. From GWAS to clinical utility in Parkinson's disease. Lancet 2011;377:613-614.
7. Saunders-Pullman R, Wang C, Stanley K, Bressman SB. Diagnosis and referral delay in women with Parkinson's disease. Gender Med 2011;8:209-217.
8. Cervantes AA, Rodriguez VM, Camacho OA, Gonzalez LP, Lopez RM, Estrada BI, Zuniga RC, Otero CE. Time from motor symptoms onset to diagnosis of Parkinson's disease in Mexico. Gac Med Mex 2014;150(Suppl2):242-247.